Ken Fisher Stock Portfolio: 12 Best Stocks to Buy

According to Ken Fisher, the founder and executive chairman of Fisher Investments, American investors continue to undervalue global diversity.

Thermo Fisher: The Market Is Missing The Point, This Pullback Is A Buy (Rating Update)

Thermo Fisher Scientific targets $47.2B revenue and $24.80 EPS with 4% organic growth and Clario acquisition gains. Read why ...

Thermo Fisher signals 2026 revenue guidance of up to $47.2B with 6%–8% EPS growth while advancing AI and strategic acquisitions

Q4 2025 earnings call recap: revenue, EPS, 2026 guidance, AI partnerships and Clario deal impact—get key takeaways for investors now.
StockStory.org on MSN

Thermo Fisher (NYSE:TMO) posts better-than-expected sales in Q4 CY2025

Life sciences company Thermo Fisher (NYSE:TMO) reported Q4 CY2025 results , with sales up 7.2% year on year to $12.22 billion ...